As part of these efforts, athletes will be provided with an eco-friendly welcome kit, which will include fully eco-friendly products, according to a release from the National Games. The Tribune ...

Gregory Mattingly, MD, president, Midwest Research Group, founding partner, St. Charles Psychiatric Associates, discusses the approval of Spravato for treatment-resistant depression. PE: How does ...

Drug is the first and only approved monotherapy for refractory major depressive disorder. (HealthDay News) — The US Food and Drug Administration has approved Spravato (esketamine) CIII nasal ...

Let us help you take the next step toward your future at Concordia! The Welcome Centre is in the Library Building (LB) on the Sir George Williams Campus. We have our own entrance at the corner of De ...

Parkside Psychiatric Hospital in Tulsa has an on-site Spravato outpatient clinic that sees over 20 patients per week. According to Parkside, these patients are seen at least twice a week for the ...

The Food and Drug Administration (FDA) recently approved the nasal spray Spravato for the treatment of MDD in those who have not responded to at least two oral antidepressants. Hundreds of ...

As part of these efforts, athletes will be provided with an eco-friendly welcome kit, which will include fully eco-friendly products, according to a release from the National Games. The eco-friendly ...

The FDA’s latest approval of the nasal spray Spravato (esketamine) CIII marks a major shift in how major depressive disorder is managed, allowing people who have tried at least two oral ...